| Host: |
Goat |
| Applications: |
IHC/WB |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Goat polyclonal antibody anti-VAMP5 (C-Term) is suitable for use in Immunohistochemistry and Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Lyophilised |
| Purification: |
IgG purified |
| Dilution Range: |
IHC, WB. A dilution of 1:300 to 1:2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications. |
| Storage Instruction: |
Maintain the lyophilised/reconstituted antibodies frozen at-20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, Glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
| Gene Symbol: |
VAMP5 |
| Gene ID: |
10791 |
| Uniprot ID: |
VAMP5_HUMAN |
| Immunogen Region: |
C-Term |
| Specificity: |
Specific for VAMP5. |
| Immunogen: |
A synthetic peptide from the c-terminal region of human VAMP5 conjugated to an immunogenic carrier protein was used as the antigen. |
| Function | May participate in trafficking events that are associated with myogenesis, such as myoblast fusion and/or GLUT4 trafficking. |
| Protein Name | Vesicle-Associated Membrane Protein 5Vamp-5Myobrevin |
| Cellular Localisation | Cell MembraneSingle-Pass Type Iv Membrane ProteinEndomembrane SystemGolgi ApparatusTrans-Golgi Network MembraneAssociated With The Plasma Membrane As Well As Intracellular Perinuclear And Peripheral Vesicular Structures Of MyotubesAssociated With The Trans-GolgiBut Not With The Cis-Golgi Apparatus |
| Alternative Antibody Names | Anti-Vesicle-Associated Membrane Protein 5 antibodyAnti-Vamp-5 antibodyAnti-Myobrevin antibodyAnti-VAMP5 antibodyAnti-HSPC191 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
